Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies

Thrombosis and Haemostasis

Volumn 113, Issue 5, 2015, Pages 916-930

  Ambrosino, Pasquale ^a   Lupoli, Roberta ^a   di Minno, Alessandro ^a   Tasso, Marco ^a   Peluso, Rosario ^a   di Minno, Matteo Nicola Dario ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Cardiovascular risk; Carotid plaques; Intima media thickness; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RHEUMATOID FACTOR; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; DAS28; DISEASE ASSOCIATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFLAMMATION; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ADULT; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COMMON CAROTID ARTERY; COMPLICATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOMARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS;

EID: 84930187348     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-11-0921     Document Type: Review

References (93)

1. Scarno A, Perrotta FM, Cardini F, et al. Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis. World J Orthop 2014; 5: 328–335.
2. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005; 4: 130–136.
3. Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 2012; 18: S295-S302.
4. Mitchell DM, Spitz PW, Young DY, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986; 29: 706–714.
5. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective follow up. J Rheumatol 1984; 11: 158–161.
6. Monson RR, Hall AP. Mortality among arthritics. J Chronic Dis 1976; 29: 459–467.
7. Prior P, Symmons DPM, Scott DL, et al. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984; 23: 92–99.
8. Mutru O, Laakso M, Isomäki H, et al. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 1985; 290: 1797–1799.
9. Di Minno MN, Iervolino S, Lupoli R, et al. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost 2012; 38: 497–505.
10. Scarno A, Perrotta FM, Cardini F, et al. Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis. World J Orthop 2014; 5: 328–335.
11. Minaur NJ, Jacoby RK, Cosh JA, et al. Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl 2004; 69: 3–8.
12. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008; 59: 1690–1697.
13. La Montagna G, Cacciapuoti F, Buono R, et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diab Vasc Dis Res 2007; 4: 130–135.
14. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008; 121: S3–8.
15. Simon A, Chironi G, Levenson J. The performance of subclinical arterial disease detection as screening test for coronary heart disease. Hypertension 2006; 48: 392–396.
16. Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther 2002; 16: 341–351.
17. de Groot E, Hovingh GK, Wiegman A, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004; 109: III33-III38.
18. O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14–22.
19. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 1997; 146: 483–494.
20. Belcaro G, Nicolaides AN, Ramaswami G, et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study the CAFES-CAVE study. Atherosclerosis 2011; 156: 379–387.
21. Georgiadis AN, Voulgari PV, Argyropoulou MI, et al. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum 2008; 38: 13–19.
22. Gerli R, Sherer Y, Vaudo G, et al. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann NY Acad Sci 2005; 1051: 281–290.
23. Klimek E, Mikołajczyk T, Sulicka J, et al. Blood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activity. Biomed Res Int 2014; 2014: 736853.
24. Tyrrell PN, Beyene J, Feldman BM, et al. Rheumatic disease and carotid intimamedia thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2010; 30: 1014–1026.
25. van Sijl AM, Peters MJ, Knol DK, et al. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum 2011; 40: 389–397
26. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Medicine 2009; 6: e1000097.
27. Wells GA, Shea B, O’Connell D, et al. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed October 2,. 2005
28. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560.
29. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. Br Med J 2001; 323: 101–105.
30. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–463.
31. Bartoloni Bocci E, Marchesi S, Delle Monache F, et al. Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity. Reumatismo 2005; 57: 16–21.
32. Chatterjee Adhikari M, Guin A, Chakraborty S, et al. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 2012; 41: 669–675.
33. Ciftci O, Yilmaz S, Topcu S, et al. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 2008; 198: 332–327.
34. Cuomo G, Di Micco P, Niglio A, et al. Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disability. Reumatismo 2004; 56: 242–246.
35. Daza L, Aguirre M, Jimenez M, et al. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol 2007; 26: 533–537.
36. Del Rincón I, Williams K, Stern MP, et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003; 48: 1833–1840.
37. Fan CY, Zhang ZY, Mei YF, et al. Impaired brachial artery flow-mediated dilation and increased carotid intima-media thickness in rheumatoid arthritis patients. Chin Med J 2012; 125: 832–837.
38. Hannawi S, Haluska B, Marwick TH, et al. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 2007; 9: R116.
39. Holmes MV, Jiang B, McNeill K, et al. Paradoxical association of C-reactive protein with endothelial function in rheumatoid arthritis. PLoS One 2010; 5: e10242.
40. Jonsson SW, Backman C, Johnson O, et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597–2602.
41. Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intimamedia detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 1489–1497.
42. Lee JH, Cho KI, Kim SM. Carotid arterial stiffness in patients with rheumatoid arthritis assessed by speckle tracking strain imaging: its association with carotid atherosclerosis. Clin Exp Rheumatol 2012; 30: 720–728.
43. Pahor A, Hojs R, Gorenjak M, et al. Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. Rheumatol Int 2006; 27: 119–123.
44. Park YB, Ahn CW, Choi HK, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002; 46: 1714–1719.
45. Pereira I, Laurindo I, Burlingame R, et al. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. Joint Bone Spine 2008;75: 416–421.
46. Pereira IA, Laurindo IM, Zimmermann AF, et al. Single measurements of C-reactive protein and disease activity scores are not predictors of carotid atherosclerosis in rheumatoid arthritis patients. Acta Reumatol Port 2009; 34: 58–64.
47. Pieringer H, Schumacher S, Stuby U, et al. Augmentation index and large-artery remodeling in patients with longstanding rheumatoid arthritis compared with healthy controls. Semin Arthritis Rheum 2009; 39: 163–169.
48. Provan SA, Semb AG, Hisdal J, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis 2011; 70: 812–817.
49. Ristic GG, Lepic T, Glisic B, et al. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology 2010; 49: 1076–1081.
50. Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005; 46: 194–199.
51. Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006; 144: 249–256.
52. Schott LL, Kao AH, Cunningham A, et al. Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis? J Womens Health 2009; 18: 21–29.
53. Shakeri A, Bazzaz MB, Khabbazi A, et al. Common carotid intima-media thickness in patients with late rheumatoid arthritis; what is the role of gender? Pak J Biol Sci 2011; 14: 812–816.
54. Stamatelopoulos KS, Kitas GD, Papamichael CM, et al. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol 2009; 29: 1702–1708.
55. Stamatelopoulos KS, Kitas GD, Papamichael CM, et al. Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis 2010; 212: 305–309.
56. Surdacki A, Martens-Lobenhoffer J, Wloch A, et al. Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2007; 56: 809–819.
57. Södergren A, Karp K, Boman K, et al. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther 2010; 12: R158.
58. Turkyilmaz AK, Devrimsel G, Kirbas A, et al. Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. Rheumatol Int 2013; 33: 2751–2756.
59. Tutoglu A, Boyaci A, Boyaci N, et al. Is There Any Relationship between Joint Destruction and Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis? J Phys Ther Sci 2014; 26: 1093–1096.
60. Veselinovic MV, Zivkovic VI, Toncev S, et al. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis. Vasa 2012; 41: 343–351.
61. Ahmed HM, Youssef M, Mosaad YM. Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clin Rheumatol 2010; 29: 1237–1243.
62. Im CH, Kim NR, Kang JW, et al. Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis. Rheumatology 2014; Epub ahead of print.
63. Kobayashi H, Giles JT, Polak JF, et al. Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol 2010; 37: 730–739.
64. Pamuk ON, Unlü E, Cakir N. Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. J Rheumatol 2006; 33: 2447–2452.
65. Semb AG, Rollefstad S, Provan SA, et al. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol 2013; 40: 359–368.
66. Abu-Shakra M, Polychuck I, Szendro G, et al. Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis: a controlled study. Semin Arthritis Rheum 2005; 35: 18–23.
67. Ahmad S, Garg S, Dhar M, et al. Predictors of atherosclerosis in rheumatoid arthritis. Vasa 2012; 41: 353–359.
68. Sahari NS, Shaharir SS, Ismail MR, et al. Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors. Mod Rheumatol 2014; Epub ahead of print.
69. Gonzalez-Juanatey C, Llorca J, Testa A, et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine 2003; 82: 407–413.
70. Grover S, Sinha RP, Singh U, et al. Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 2006; 33: 244–247.
71. Kerekes G, Szekanecz Z, Dér H, et al. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008; 35: 398–406.
72. Mahajan V, Handa R, Kumar U, et al. Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J Assoc Physicians India 2008; 56: 587–590.
73. Akrout R, Fourati H, Mnif E, et al. Increased cardiovascular risk and premature atherosclerosis in rheumatoid arthritis. Ann Cardiol Angeiol 2012; 61: 267–273.
74. Alkaabi JK, Ho M, Levison R, et al. Rheumatoid arthritis and macrovascular disease. Rheumatology 2003; 42: 292–297.
75. Carotti M, Salaffi F, Mangiacotti M, et al. Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness. Reumatismo 2007; 59: 38–49.
76. Cigliano L, Spagnuolo MS, Cuomo G, et al. Apolipoprotein A-I-dependent cholesterol esterification in patients with rheumatoid arthritis. Life Sci 2005; 77: 108–120.
77. Coaccioli S, Capitò G, Valentini M, et al. Intima-media thickness of common carotid as cardiovascular risk factor in rheumatoid arthritis and metabolic disorders. Clin Ter 2007; 158: 505–508.
78. Dessein PH, Woodiwiss AJ, Norton GR, et al. Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study. Arthritis Res Ther 2013; 15: R96.
79. Naredo E, Möller I, Corrales A, et al. Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs. Rheumatology 2013; 52: 376–381.
80. Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, et al. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology 2003; 42: 645–651.
81. El-Barbary AM, Kassem EM, El-Sergany MA, et al. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide. J Rheumatol 2011; 38: 828–834.
82. Zampeli E, Protogerou A, Stamatelopoulos K, et al. Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther 2012; 14: R44.
83. Singh H, Goyal M, Sen J, et al. Correlation of intima-media thickness (as a marker of atherosclerosis) with activity and duration of rheumatoid arthritis using carotid ultrasound. JIACM 2011; 12: 15–20.
84. Barbarroja N, Pérez-Sanchez C, Ruiz-Limon P, et al. Anticyclic Citrullinated Protein Antibodies Are Implicated in the Development of Cardiovascular Disease in Rheumatoid Arthritis. Arterioscler Thromb Vasc Biol 2014; Epub ahead of print.
85. Mohan A, Sada S, Kumar BS, et al. Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. Indian J Med Res 2014; 140: 379–386.
86. van den Oever IA, van Sijl AM, Nurmohamed MT. Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Ther Adv Musculoskelet Dis 2013; 5: 166–181.
87. Wang F, Wang NS, Yan CG, et al. The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 2007; 26: 768–771.
88. Jacobsson LT, Turesson C, Gülfe A, et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patientswith rheumatoid arthritis. J Rheumatol 2005; 32: 1213–1218.
89. Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 2011; 70: 8–14.
90. Farragher T, Goodson N, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis 5. Arthritis Rheum 2008; 58: 359–369.
91. Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325–331.
92. van der Meer IM, Bots ML, Hofman A, et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: The Rotterdam Study. Circulation 2004; 109: 1089–1094.
93. Bots ML, Taylor AJ, Kastelein JJ, et al. Rate of change in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view. J Hypertens 2012; 30: 1690–1696.